Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.
about
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) miceAntigen-based immunotherapy for autoimmune disease: current statusAdvancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient miceStem cell therapy for diabetes mellitusDisease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialUnderstanding diseases by mouse click: the promise and potential of computational approaches in Systems BiologyApproaches in type 1 diabetes research: A status report.Immunologic endocrine disorders.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.The road not taken: a path to curing type 1 diabetes?Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppressionIncidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma.Efforts to prevent and halt autoimmune beta cell destruction.Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential.Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.An update on the use of NOD mice to study autoimmune (Type 1) diabetes.Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.Case report: type 1 diabetes in monozygotic quadruplets.Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes.Antigen targets of type 1 diabetes autoimmunityMAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD miceOn the etiology of type 1 diabetes: a new animal model signifying a decisive role for bacteria eliciting an adverse innate immunity response.Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model.Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD miceCTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.The effect of diabetes-associated autoantigens on cell processes in human PBMCs and their relevance to autoimmune diabetes development.Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials.New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes.Type 1 diabetes mellitus: primary, secondary, and tertiary prevention.Changes in autoreactive T cell avidity during type 1 diabetes development.Stem cells and a cure for type 1 diabetes?Autologous hematopoietic stem cell transplantation for type 1 diabetes.Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futureNatural evolution, prediction, and prevention of type 1 diabetes in youth.
P2860
Q21562482-860A13EA-3229-43C9-ADB4-0E5DF34275D3Q26852915-13C65309-82F6-4B52-AEE6-C2E3B2FE6D0BQ27008307-751E930A-22D8-4F40-8DB8-D38C225E5A54Q27011453-49665773-A9D7-453D-A19B-550EE00CE180Q28081034-38536B1E-8F92-47D9-8493-8589301479F4Q28554636-8C71B38F-FB7E-4388-8EAF-1633FAD5660DQ28755845-838E3960-6506-4AF8-B1E7-28159185B1E3Q33616086-498774A3-EA89-4708-B205-44C5CB0DE401Q33714100-43BED62D-F96F-4C11-923D-2E5B8B367006Q33750748-61380037-B414-4D01-A80D-148345FD0FCBQ33859301-12CD82C1-7996-4AF3-99CA-85A46468026AQ33869793-96B0257E-96DD-4589-8497-05FDCDF1B2B8Q33909053-9F1DDF22-AA56-47E8-9D65-8B13A9F0AABFQ33932615-AD65F27B-DAC1-471F-912E-EB54CD75929EQ34023585-006C78D1-E74A-47E3-B255-58DC713F097CQ34077363-27D7AA83-5127-4329-B31C-F53A7E71BFE2Q34082782-997932F9-F6FF-44B1-A29C-33D794C3C297Q34318993-9B61E026-9AF9-4AA2-BAD4-22D497B6B1CEQ34355286-09EC1C77-BF6D-440F-9A15-D53B6733E57AQ34508281-A00F4D33-B718-4BBF-A8FD-0501D9FC61CEQ34706913-D10F1CA0-4C8E-4B2B-ADB5-B45B1D702CF4Q35060161-51BA5A1B-AD00-4732-8AB5-1A1F54DA9DE6Q35837650-60618FB8-7F6C-4594-80D3-92DAE65F25A3Q35851405-0D45E00E-2D40-4B1A-9756-D526FD5FC90EQ35852999-EDA3B3B5-F88B-4388-A1B3-050E18E9466AQ35891738-9687B503-CF5D-46F7-8FA0-FD7A0F300A71Q36355619-167440C0-FDAB-4B7C-8AF1-A53E94149F5FQ36637650-CA9CD6B9-5C94-42A2-9D39-7BFD3A75F635Q36755359-40084705-FE21-4BE7-8A5D-792A3BD4B835Q36890836-0ED3864E-FC0E-46D5-B613-A5AA0141B941Q36959641-49453EE5-2CB4-4DA5-844C-5A88EAC8A328Q37023012-C1AEAEB0-7499-489D-AC65-E87105FAB12AQ37056758-B85C31D1-FE59-4764-B3EF-649291726D87Q37240506-72F1FF72-6078-4B71-A70A-54053D23EC84Q37252933-AA6D5181-AB08-4AD9-BA76-AA1531E05A1FQ37289023-5B304169-5363-47AD-B79D-62666F16743FQ37354064-B2CB70DF-8919-4E86-B604-E625B647338BQ37361377-BAB2F671-E8E7-4D9F-B49C-69672D5D5A1BQ37364899-003F6FD4-B06A-453F-BAA8-8D7833DCBBD6Q37373473-BAE94D88-A8FA-406E-AAA4-883162BF88A1
P2860
Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Translational mini-review seri ...... pproaches for type 1 diabetes.
@ast
Translational mini-review seri ...... pproaches for type 1 diabetes.
@en
type
label
Translational mini-review seri ...... pproaches for type 1 diabetes.
@ast
Translational mini-review seri ...... pproaches for type 1 diabetes.
@en
prefLabel
Translational mini-review seri ...... pproaches for type 1 diabetes.
@ast
Translational mini-review seri ...... pproaches for type 1 diabetes.
@en
P2093
P2860
P1476
Translational mini-review seri ...... pproaches for type 1 diabetes.
@en
P2093
M von Herrath
T Staeva-Vieira
P2860
P356
10.1111/J.1365-2249.2007.03328.X
P577
2007-04-01T00:00:00Z